Stray Dog
EN中文
EN中文

Prices are Hyperliquid perpetual futures: contracts that track each stock and trade 24/7. They are not exchange prices and can differ from them, most of all while US markets are closed. Change is over 24 hours. For information only.

  • TSLA—
  • PLTR—
  • HIMS—
  • SPCX—
  • SOFI—
  • BTC—
…Loading prices
TSLA

NHTSA investigation, Nevada Robotaxi and Jefferies downgrade

Sources (6)

Tesla's regulatory and litigation exposure has escalated from a dispute over data methodology to a concrete fatality and a federal investigation. Robotaxi shows its first evidence of state expansion, with the Nevada filing. Jefferies flags a new structural risk: TSLA becoming a 'SpaceX proxy stock', divorced from its own fundamentals.

Key evidence

  • On 19 Jun in Katy, Texas, a Model 3 crashed at high speed into a residential home and killed a 76-year-old woman. NHTSA opened a Special Crash Investigation, the deepest level of inquiry, on 22 Jun.
  • FSD activation at the time of the crash has not been confirmed, and police declined to disclose it. Tesla pre-emptively pushed back against the 'autopilot mode' characterisation.
  • The case falls within the scope of the existing engineering analysis of 3.2 million FSD vehicles, which was upgraded in March. This is the last procedural step before a mandatory recall.
  • This is the first specific fatal case to enter the federal investigation procedure since last week's 'misleading safety data' controversy (a senator's deadline of 7 Jul and the European TCMV on 30 Jun).
  • TeslaDeaths.com tracks at least 65 Autopilot and FSD-related deaths.
  • On 19 Jun Tesla filed an application for a Nevada autonomous vehicle network licence (USPTO serial 99894747). It is the first new state-level deployment beyond Texas.
Show 7 more
  • This maps to Musk's commitment on the April earnings call to be 'operating in a dozen-plus states by year end'.
  • It is still an application, not an approval, but it is directional confirmation of the ramp.
  • On 22 Jun Jefferies raised its TSLA target from $350 to $375, which still implies about 7% downside.
  • Jefferies adds a new risk framing: hotter expectations of a Tesla-SpaceX merger could turn TSLA into a 'SpaceX tracking/proxy stock'. The price would no longer reflect its own fundamentals and would instead be hijacked by the space-asset narrative.
  • This counterbalances the multi-day bullish narrative that a merger is positive: the hotter the merger expectations, the weaker TSLA's standalone valuation anchor.
  • MarketBeat's current consensus is Hold, with an average target of $405.06.
  • The latest close, on 22 Jun, was about $400, and the stock is down about 10% year to date.

Catalysts to watch

  • 2 Jul: Q2 delivery data (consensus about 400,000 vehicles)
  • 7 Jul: a senator's deadline on the misleading safety data inquiry
  • 22 Jul: Q2 earnings
  • 30 Jun: Europe TCMV decision
  • Outcome of the NHTSA Special Crash Investigation into the Katy fatality
Show 2 more
  • Pending approval of the Nevada autonomous vehicle network licence
  • Final step in the engineering analysis of 3.2 million FSD vehicles (a potential trigger for a mandatory recall)

Risks

  • Regulatory escalation: a fatality case and a federal investigation move the issue beyond a data dispute to concrete liability
  • Risk of a mandatory recall of 3.2 million FSD vehicles
  • Expanding litigation exposure (TeslaDeaths.com tracks at least 65 deaths)
  • SpaceX-proxy risk: TSLA's valuation becomes hostage to the merger narrative and decouples from auto and AI fundamentals
  • Q2 deliveries miss the consensus of about 400,000
  • Robotaxi state expansion timeline slips against the 'dozen-plus states by year end' commitment

Sources 6

  1. NHTSA Special Crash Investigation announcement, 22 Jun
  2. Tesla official statement on the Katy crash
  3. USPTO filing, serial 99894747 (Nevada autonomous vehicle licence application)
  4. Jefferies research note, 22 Jun, raising the target to $375
  5. MarketBeat consensus data
  6. TeslaDeaths.com independent tracker

A brief is a lead for our research, not a verified conclusion or advice.